Drug | Concentration (μM) | k′nb/(1 + k′) = nt–(1/KA)k′Vm | R2 | KA (104 L/mol) | nt (× 10−9 mol/L) |
---|---|---|---|---|---|
Atropine | 250–1000 | k′nb/(1 + k′) = 2.42 × 10–8–1.25 × 10–5 k′Vm | 0.993 | 8.00 ± 0.20 | 2.42 ± 0.60 |
1250–4000 | k′nb/(1 + k′) = 1.41 × 10–7–1.02 × 10–4 k′Vm | 0.990 | 0.98 ± 0.02 | 141.00 ± 2.83 | |
Pirenzepine | 10–150 | k′nb/(1 + k′) = 3.75 × 10–9–3.84 × 10–6 k′Vm | 0.986 | 26.04 ± 0.82 | 3.75 ± 0.12 |
300–1800 | k′nb/(1 + k′) = 3.14 × 10–8–4.27 × 10–5 k′Vm | 0.987 | 2.34 ± 0.07 | 31.40 ± 0.87 | |
Darifenacin | 500–2000 | k′nb/(1 + k′) = 2.76 × 10–8–1.29 × 10–5 k′Vm | 0.977 | 7.75 ± 0.20 | 27.60 ± 0.35 |
Solifenacin | 200–1000 | k′nb/(1 + k′) = 4.40 × 10–8–8.33 × 10–6 k′Vm | 0.976 | 12.01 ± 0.08 | 44.00 ± 0.26 |